Furthermore, we found that the ghrelin serum levels in patients treated with the oral administration of CLZ for 6 months were not significantly affected, but those in patients treated with the oral administration of OLZ for 6 months significantly decreased compared with those in patients with psychosis who were not treated, as shown in Figure 2D. This evidence concerns the gene GHRL and psychotic disorder.